|1.99||-0.01 / -0.50%|
Data as of 3:59pm ET
|1.99||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +201.51% increase from the last price of 1.99.
The current consensus among 3 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.